Parkinson's Disease

Parkinson's Disease

SEP-363856: a future option for Parkinson’s disease psychosis 1:10
SEP-363856: a future option for Parkinson’s disease psychosis
Stuart Isaacson • 21 Apr 2021
Carbidopa/levodopa enteral suspension for PD 1:38
Carbidopa/levodopa enteral suspension for PD
Gian Pal • 30 Apr 2021
Benefits and challenges of telemedicine for PD 3:25
Benefits and challenges of telemedicine for PD
Esther Cubo • 28 Apr 2021
DBS vs MRI-guided focused ultrasound for tremor 2:18
DBS vs MRI-guided focused ultrasound for tremor
Gian Pal • 30 Apr 2021
Treatment options for Parkinson’s disease psychosis 3:39
Treatment options for Parkinson’s disease psychosis
Stuart Isaacson • 21 Apr 2021
The efficacy and safety of SEP-363856 for Parkinson’s disease psychosis 3:44
The efficacy and safety of SEP-363856 for Parkinson’s disease psychosis
Stuart Isaacson • 21 Apr 2021
Multidisciplinary telemedicine approach for falls prevention in Parkinson’s disease 4:41
Multidisciplinary telemedicine approach for falls prevention in Parkinson’s disease
Esther Cubo • 28 Apr 2021
Integrated care and self-management for Parkinson’s disease 3:01
Integrated care and self-management for Parkinson’s disease
Tiago Mestre • 26 Apr 2021
Randomized trial of FUS subthalamotomy for PD 4:10
Randomized trial of FUS subthalamotomy for PD
José Obeso et al. • 22 Apr 2021
Future advances in deep brain stimulation device technology 3:31
Future advances in deep brain stimulation device technology
Jerrold Vitek • 16 Apr 2021
Optimization of MRI-guided FUS in Parkinson’s disease 3:12
Optimization of MRI-guided FUS in Parkinson’s disease
José Obeso et al. • 22 Apr 2021
INTREPID trial: device features and study design 5:06
INTREPID trial: device features and study design
Jerrold Vitek • 16 Apr 2021
MRI-guided focused ultrasound for Parkinson’s disease 1:41
MRI-guided focused ultrasound for Parkinson’s disease
José Obeso et al. • 22 Apr 2021
New perspectives on focused ultrasound in neurological disorders 2:07
New perspectives on focused ultrasound in neurological disorders
José Obeso • 22 Apr 2021
Updates on the INTREPID trial: 4-year follow-up 5:11
Updates on the INTREPID trial: 4-year follow-up
Jerrold Vitek • 16 Apr 2021
Hypersomnia management in MS and Parkinson’s disease 2:18
Hypersomnia management in MS and Parkinson’s disease
Chantale Branson • 7 Apr 2021
The content of VJNeurology is intended for healthcare professionals